These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21683106)

  • 1. The pathological prion protein forms ionic conductance in lipid bilayer.
    Paulis D; Maras B; Schininà ME; di Francesco L; Principe S; Galeno R; Abdel-Haq H; Cardone F; Florio T; Pocchiari M; Mazzanti M
    Neurochem Int; 2011 Aug; 59(2):168-74. PubMed ID: 21683106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural localization of prion proteins: physiological and pathological implications.
    Fournier JG; Escaig-Haye F; Grigoriev V
    Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prion peptide forms ion channels in planar lipid bilayers.
    Berest V; Rutkowski M; Rolka K; Łegowska A; Debska G; Stepkowski D; Szewczyk A
    Cell Mol Biol Lett; 2003; 8(2):353-62. PubMed ID: 12813570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel.
    Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D
    J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmissible spongiform encephalopathies.
    Lasmézas CI
    Rev Sci Tech; 2003 Apr; 22(1):23-36. PubMed ID: 12793772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains.
    Ersdal C; Goodsir CM; Simmons MM; McGovern G; Jeffrey M
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):259-71. PubMed ID: 19473293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
    Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
    J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
    Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
    Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanidine hydrochloride extraction and detection of prion proteins in mouse and hamster prion diseases by ELISA.
    Kang SC; Li R; Wang C; Pan T; Liu T; Rubenstein R; Barnard G; Wong BS; Sy MS
    J Pathol; 2003 Apr; 199(4):534-41. PubMed ID: 12635145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray diffraction of scrapie prion rods and PrP peptides.
    Nguyen JT; Inouye H; Baldwin MA; Fletterick RJ; Cohen FE; Prusiner SB; Kirschner DA
    J Mol Biol; 1995 Sep; 252(4):412-22. PubMed ID: 7563061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A special report I. Prion protein (Prp)--amyloid plaques in the transmissible spongiform encephalopathies (TSEs) or prion disease revisited.
    Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
    Pol J Pathol; 2001; 52(4):169-86. PubMed ID: 11915178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.